Hunan Fangsheng Pharmaceutical Co (SHSE:603998) Capital Expenditure : ¥-111.96 Mil (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Hunan Fangsheng Pharmaceutical Co's cash flow for capital expenditures for the three months ended in Sep. 2024 was ¥-18 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-111.96 Mil.

Hunan Fangsheng Pharmaceutical Co Capital Expenditure Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co Capital Expenditure Chart

Hunan Fangsheng Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-199.45

-167.76

-184.71

-171.25

-218.78

Hunan Fangsheng Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Capital Expenditure	Get a 7-Day Free Trial															-75.09	-32.50	-41.86	-19.96	-17.64

Hunan Fangsheng Pharmaceutical Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-111.96 Mil.

Hunan Fangsheng Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » Capital Expenditure

Traded in Other Exchanges

N/A

Address

Lu days Road 19, Yuelu District, Hunan Province, CHN, 410205

Website

http://www.fangsheng.com.cn

Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.

Executives

He Shi	senior management
Xiao Han Qing	senior management
Liu Xin He	senior management
Chen Bo	Director
Chen Ai Chun	Director
Li Zhi Heng	senior management
Zhou Wei En	senior management
Zhang Qing Hua	Director
Huang Min	Director
Zhou Xiao Li	senior management
Fang Jin Cheng	Director
Fang Chuan Long	Supervisors
Tan Yuan Ming	Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines